Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months

References

• Carvalho TL, de Almeida LM, Lorega CM, Barata MF, Ferreira ML, de Brito-Marques PR, et al. Depression and anxiety in individuals with amyotrophic lateral sclerosis: a systematic review. Trends Psychiatry Psychother. 2016;38:1–5.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC; 1994.
   Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. (1996). Manual for the Beck depression inventory-II. San Antonio, TX: Psychological Corporation, 1(82), 10–1037.
   Google Scholar
• Pagnini F, Manzoni GM, Tagliaferri A, Gibbons CJ. Depression and disease progression in amyotrophic lateral sclerosis: a comprehensive meta-regression analysis. J Health Psychol. 2015;20:1107–28.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82–90.
   PubMed Web of Science ®Google Scholar
• Kurt A, Nijboer F, Matuz T, Kubler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs. 2007;21:279–91.
   PubMed Web of Science ®Google Scholar
• Pisa FE, Logroscino G, Casetta A, Cecotti L, Verriello L, Bratina A, et al. The use of antidepressant medication before and after the diagnosis of amyotrophic lateral sclerosis: a population-based cohort study. Neuroepidemiology 2015;44:91–8.
   PubMed Web of Science ®Google Scholar
• Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:109–12.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El Escorial "clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci. 1994;124:96–107.
   PubMed Web of Science ®Google Scholar
• Meader N, Mitchell AJ, Chew-Graham C, Goldberg D, Rizzo M, Bird V, et al. Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. Br J Gen Pract. 2011;61:e808–e820.
   PubMed Web of Science ®Google Scholar
• The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med 1998;28:551–8.
   PubMed Web of Science ®Google Scholar
• Young CA, Mills R, Al-Chalabi A, Burke G, Chandran S, Dick DJ, et al. Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF. Amyotroph Lateral Scler Frontotemporal Degener 2020;1–9.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• EuroQol Research Foundation. EQ-5D-5L User Guide; 2019.
   Google Scholar
• Balendra R, Jones A, Jivraj N, Knights C, Ellis CM, Burman R, et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:279–84.
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata statistical software. Release 15 ed. College Station, TX: StataCorp LLC; 2017.
   Google Scholar
• Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22:209–12.
   Web of Science ®Google Scholar
• Wallis S. Binomial confidence intervals and contingency tests: mathematical fundamentals and the evaluation of alternative methods. J Quant Linguist. 2013;20:178–208.
   Web of Science ®Google Scholar
• Jones BL, Nagin DS. A note on a Stata plugin for estimating group-based trajectory models. Sociol Methods Res. 2013;42:608–13.
   Web of Science ®Google Scholar
• Haviland AM, Jones BL, Nagin DS. Group-based trajectory modeling extended to account for nonrandom participant attrition. Sociol Methods Res. 2011;40:367–90.
   Web of Science ®Google Scholar
• Bozdogan H. Model selection and Akaike's Information Criterion (AIC): the general theory and its analytical extensions. Psychometrika 1987;52:345–70.
   Web of Science ®Google Scholar
• Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38.
   PubMed Web of Science ®Google Scholar
• Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771–6.
   PubMed Web of Science ®Google Scholar
• Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha TS, et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2009;66:785–95.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Albert SM, Del Bene ML, O'Sullivan I, Tider T, Rowland LP, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005;65:62–7.
   PubMed Web of Science ®Google Scholar
• Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, et al. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021;373:n972.
   PubMedGoogle Scholar
• Rabkin J, Goetz R, Murphy JM, Factor-Litvak P, Mitsumoto H. Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort. Neurology 2016;87:1320–8.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62:271–9.
   PubMed Web of Science ®Google Scholar
• Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology 1999;52:1434–40.
   PubMed Web of Science ®Google Scholar
• Covic T, Pallant JF, Tennant A, Cox S, Emery P, Conaghan PG. Variability in depression prevalence in early rheumatoid arthritis: a comparison of the CES-D and HAD-D Scales. BMC Musculoskelet Disord. 2009;10:18.
   PubMed Web of Science ®Google Scholar
• Heidari ME, Nadali J, Parouhan A, Azarafraz M, Tabatabai SM, Irvani SSN, et al. Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: a systematic review and meta-analysis. J Affect Disord. 2021;287:182–90.
   PubMed Web of Science ®Google Scholar
• Yusuf FLA, Ng BC, Wijnands JMA, Kingwell E, Marrie RA, Tremlett H. A systematic review of morbidities suggestive of the multiple sclerosis prodrome. Expert Rev Neurother. 2020;20:799–819.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Callagher P, Gardham J, Mitchell C, Dixon M, Addison-Jones R, et al. Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)–a 20-year review: can we do better? Amyotroph Lateral Scler. 2010;11:537–41.
   PubMed Web of Science ®Google Scholar
• Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci. 2020;417:117054.
   PubMed Web of Science ®Google Scholar
• Gomez-Lumbreras A, Ferrer P, Ballarín E, Sabaté M, Vidal X, Andretta M, et al. Study of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use? J Affect Disord. 2019;249:278–85.
   PubMed Web of Science ®Google Scholar
• Mori M, Krumholz HM, Allore HG. Using latent class analysis to identify hidden clinical phenotypes. JAMA 2020;324:700–1.
   PubMed Web of Science ®Google Scholar
• Malaju MT, Alene GD, Azale T. Longitudinal functional status trajectories and its predictors among postpartum women with and without maternal morbidities in Northwest Ethiopia: a group based multi-trajectory modelling. BMJ Glob Health. 2022;7:e007483.
   PubMed Web of Science ®Google Scholar
• Straub L, Huybrechts KF, Hernández-Díaz S, Zhu Y, Vine S, Desai RJ, et al. Trajectories of prescription opioid utilization during pregnancy among prepregnancy chronic users and risk of neonatal opioid withdrawal syndrome. Am J Epidemiol. 2022;191:208–19.
   PubMed Web of Science ®Google Scholar